Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Healthtrust
Argus Health
Cipla
Merck

Generated: April 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Avelumab

« Back to Dashboard

US Patents for Avelumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Avelumab ➤ Try a Free Trial Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) ➤ Try a Free Trial
Avelumab ➤ Try a Free Trial Methods of using OX40 ligand encoding polynucleotides ModernaTX, Inc. (Cambridge, MA) ➤ Try a Free Trial
Avelumab ➤ Try a Free Trial Combinations of mRNAs encoding immune modulating polypeptides and uses thereof ModernaTX, Inc. (Cambridge, MA) ➤ Try a Free Trial
Avelumab ➤ Try a Free Trial Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors Immunomedics, Inc. (Morris Plains, NJ) ➤ Try a Free Trial
Avelumab ➤ Try a Free Trial Method of treating pancreatic cancer ChemoCentryx, Inc. (Mountain View, CA) ➤ Try a Free Trial
Avelumab ➤ Try a Free Trial Apilimod for use in the treatment of renal cancer LAM Therapeutics, Inc. (Guilford, CT) ➤ Try a Free Trial
Avelumab ➤ Try a Free Trial Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS Yeda Research and Development Co., Ltd. (Rehovot, IL) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for Avelumab

Drugname Country Document Number Estimated Expiration Related US Patent
Avelumab European Patent Office 3313818 2035-06-26 ➤ Try a Free Trial
Avelumab Japan 2018527302 2035-06-26 ➤ Try a Free Trial
Avelumab World Intellectual Property Organization (WIPO) 2016210262 2035-06-26 ➤ Try a Free Trial
Avelumab European Patent Office 3394093 2035-12-23 ➤ Try a Free Trial
Avelumab World Intellectual Property Organization (WIPO) 2017112943 2035-12-23 ➤ Try a Free Trial
Avelumab Australia 2017266929 2036-05-18 ➤ Try a Free Trial
Avelumab Australia 2017268397 2036-05-18 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Farmers Insurance
Moodys
Deloitte
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.